You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Clinical biomarker for early prediction of chemotherapy-induced peripheral neuropathy
SBC: NEWVENTUREIQ LLC Topic: 102Project Summary / Abstract Chemotherapy induced peripheral neuropathy (CIPN) is a major side effect of oxaliplatin, a key drug in 1st line regimens for treating colorectal cancer. Dose-limiting CIPN prevents rt25% of patients from receiving full, maximally effective dose of oxaliplatin. In addition, 10-40% of patients receiving oxaliplatin-based therapy for colorectal cancer with develop chronic C ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
MTI-301 a SCD1 inhibitor for the treatment of NASH
SBC: MODULATION THERAPEUTICS, INC. Topic: 300Abstract: Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in children and adults associated with diet-associated hepatic lipid accumulation (steatosis), and is a common hepatic manifestation of obesity and metabolic syndromes including diabetes. Modulation Therapeutics is developing a stearoyl- coenzyme A desaturase-1 (SCD1) inhibitor for the treatment of NAFLD a ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
3D force sensing insoles for wearable, AI empowered, high-fidelity gait monitoring
SBC: Axioforce LLC Topic: NIBIBPROJECT SUMMARYLoss of functional mobility associated with aging is the leading cause of dangerous falls and loss of living independence. Approximately 60% of community-residing individuals rt80 years-old have a gait disorder, and abnormal gait patterns are associated with a greater than two-fold increased risk of institutionalization and death in comparison to age-related adults without gait impa ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Developing a clinical diagnostic tool for age-related cochlear synaptopathy.
SBC: GATEWAY BIOTECHNOLOGY, INC. Topic: NIAAge-related hearing loss (ARHL) is the predominant neurodegenerative disease of aging. Recent animal studies have demonstrated that the earliest cochlear pathology due to noise and aging involves a loss of the inner hair cell ribbon synapse. The early consequences of this synaptic loss are not believed to affect hearing sensitivity, but rather, impair speech understanding in background noise. Whil ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple Myeloma
SBC: Sarya, LLC Topic: 102PROJECT SUMMARY Sarya LLC (Sarya) is a nuclear medicine technology company formed to commercialize radiopharmaceuticals. The goal of this Fast-Track STTR is to develop a new specific imaging agent for diagnosis, staging, and treatment of the hematological cancer, multiple myeloma (MM). MM is the 2nd most common blood cancer with an estimated 32,000 new cases and 13,000 deaths per year. Accurate de ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
SROC LEO: Super-Resolved Object Characterization in Low Earth Orbit Phase II
SBC: OPHILLIA HOLDINGS INC Topic: X22DOTCSO1Abstract: SROC LEO’s programmatic objective is to significantly improve real-time space object characterization for low earth orbit (LEO) targets – specifically satellites; by uniquely combining proven super-resolution and fast kinematic methods. SROC LEO
STTR Phase II 2023 Department of DefenseAir Force -
Super-Resolved Object Characterization in Low Earth Orbit (SROC LEO)
SBC: OPHILLIA HOLDINGS INC Topic: X22DOTCSO1O Analytics Incorporated (OAI) has partnered with West Virginia University (WVU) to propose a solution to significantly improve real-time space object characterization for low earth orbit (LEO) targets – specifically satellites; by uniquely combining proven super-resolution and fast kinematic methods; that can be used with current Space Surveillance Network (SSN) sensor technology; and can be ap ...
STTR Phase I 2023 Department of DefenseAir Force -
Learning Architecture for Short-Term Forecasts of Cloud Characteristics Using Satellites (LAST FOCUS)
SBC: NEXTGEN FEDERAL SYSTEMS LLC Topic: N23AT025The Learning Architecture for Short-Term Forecasts of Cloud Characteristics Using Satellites (LAST FOCUS) introduces a novel approach and state-of-the-art ML methodologies to forecast cloud properties including, but not limited to, ceiling, optical depth, phases, and reflectance. Using a suite of cloud-observing geostationary and Low-Earth Orbiting (LEO) satellites, atmospheric profiles, and an ...
STTR Phase I 2023 Department of DefenseNavy -
Dynamhex with UMKC uses AI to help organizations quantify, manage and scale climate impact
SBC: DYNAMHEX, INC. Topic: AF21BTCSO1Dynamhex helps customers manage climate change targets and energy transition plans with data-backed, actionable and cost-effective solutions. Dynamhex uses AI models to process timely, standardized and localized data down to the component level and presen
STTR Phase I 2022 Department of DefenseAir Force -
Mitofusin Agonists to Treat Neurodegenerative Disease
SBC: Mitochondria in Motion, Inc. Topic: 104Mitofusin agonists for the treatment of neurodegenerative diseases Gerald W Dorn II, MD Mitochondria in Motion, Inc. Washington University in St Louis School of Medicine Abstract: A number of rare neurodegenerative diseases are characterized by mitochondrial fragmentation, dysmotility and dysfunction. Among these are Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease (HD), which cause ...
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health